Literature DB >> 7771451

Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years.

D F Williamson1, E Pamuk, M Thun, D Flanders, T Byers, C Heath.   

Abstract

Although 40% of US women indicate they are currently trying to lose weight, the association between intentional weight loss and longevity is unknown. The authors analyzed prospective data from 43,457 overweight, never-smoking US white women aged 40-64 years who in 1959-1960 completed a questionnaire that included questions on weight change direction, amount, time interval, and intentionality. Vital status was determined in 1972. Proportional hazards regression was used to estimate mortality rate ratios for women who intentionally lost weight compared with women who had no change in weight. Women who died within the first 3 years of follow-up were excluded. Analyses were stratified by preexisting illness and adjusted for age, beginning body mass index, alcohol intake, education, physical activity, and health conditions. In women with obesity-related health conditions (n = 15,069), intentional weight loss of any amount was associated with a 20% reduction in all-cause mortality, primarily due to a 40-50% reduction in mortality from obesity-related cancers; diabetes-associated mortality was also reduced by 30-40% in those who intentionally lost weight. In women with no preexisting illness (n = 28,388), intentional weight loss of > or = 20 lb (> or = 9.1 kg) that occurred within the previous year was associated with about a 25% reduction in all-cause, cardiovascular, and cancer mortality; however, loss of < 20 lb (< 9.1 kg) or loss that occurred over an interval of > or = 1 year was generally associated with small to modest increases in mortality. The association between intentional weight loss and longevity in middle-aged overweight women appears to depend on their health status. Intentional weight loss among women with obesity-related conditions is generally associated with decreased premature mortality, whereas among women with no preexisting illness, the association is equivocal.

Entities:  

Mesh:

Year:  1995        PMID: 7771451     DOI: 10.1093/oxfordjournals.aje.a117386

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  85 in total

1.  Treatment for morbid obesity.

Authors:  A R Carmichael
Journal:  Postgrad Med J       Date:  1999-01       Impact factor: 2.401

2.  Outdated and misleading review of orlistat.

Authors:  R Van; L Walt
Journal:  Can Fam Physician       Date:  1999-12       Impact factor: 3.275

Review 3.  Socioeconomic issues affecting the treatment of obesity in the new millennium.

Authors:  L F Martin; A Robinson; B J Moore
Journal:  Pharmacoeconomics       Date:  2000-10       Impact factor: 4.981

4.  Multifactorial approach to the primary and secondary prevention of atherosclerosis.

Authors:  Carl J Lavie; Richard V Milani
Journal:  Ochsner J       Date:  2003

5.  Long-term results of a prospective study on laparoscopic adjustable gastric banding for morbid obesity.

Authors:  Y Van Nieuwenhove; W Ceelen; A Stockman; H Vanommeslaeghe; E Snoeck; K Van Renterghem; D Van de Putte; P Pattyn
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

6.  New NHLBI clinical guidelines for obesity and overweight: will they promote health?

Authors:  W J Strawbridge; M I Wallhagen; S J Shema
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

7.  The association between weight fluctuation and mortality: results from a population-based cohort study.

Authors:  Vanessa A Diaz; Arch G Mainous; Charles J Everett
Journal:  J Community Health       Date:  2005-06

8.  Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women.

Authors:  K A McAuley; C M Hopkins; K J Smith; R T McLay; S M Williams; R W Taylor; J I Mann
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

9.  Drug treatment for obesity in the post-sibutramine era.

Authors:  Bernard M Y Cheung
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

10.  Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience.

Authors:  Alfredo Genco; Gontrand López-Nava; Christian Wahlen; Roberta Maselli; Massimiliano Cipriano; Maria Mara Arenas Sanchez; Chantal Jacobs; Michele Lorenzo
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.